Skip to main content

Table 3 Receipt of treatments by ethnicity

From: Ethnic minority inequalities in access to treatments for schizophrenia and schizoaffective disorders: findings from a nationally representative cross-sectional study

   Asian/Asian British Black/Black British Chinese/ Other Mixed LRT
Number, N/ total OR 95% CI OR 95% CI OR 95% CI OR 95% CI p value
Antipsychotic prescribing
 Not in receipt of an antipsychotic 393/10,504 1.01 0.69, 1.47 1.26 0.89, 1.77 1.24 0.62, 2.49 0.78 0.36, 1.70 0.66
 Prescribed SGA vs FGAa 4396/6769 0.91 0.75, 1.10 1.17 0.97, 1.41 0.72 0.48, 1.07 1.06 0.72, 1.56 0.13
 Prescribed depot 3336/10,504 1.07 0.90, 1.26 1.56 1.33, 1.84 0.83 0.59, 1.17 1.01 0.74, 1.40 < 0.001
 Prescribed clozapineb` 719/2793 0.76 0.55, 1.06 0.56 0.39, 0.79 0.96 0.48, 1.92 1.10 0.58, 2.08 0.01
 Prescribed > 100% BNF recommended dose 1048/10,504 0.82 0.63, 1.08 0.77 0.58, 1.02 0.88 0.52, 1.50 1.58 1.05, 2.38 0.04
 Prescribed 2+ antipsychotics, exc. clozapine 1229/10,504 1.00 0.79, 1.28 0.86 0.66, 1.11 0.77 0.46, 1.31 1.20 0.79, 1.86 0.54
Shared decision making
 Service user involved in deciding which antipsychotic prescribed 6070/10,334 0.85 0.73, 0.99 1.07 0.92, 1.26 0.93 0.68, 1.27 1.08 0.80, 1.45 0.17
 Provided with written info on medication or alternative 4244/10,455 0.97 0.83, 1.14 1.04 0.88, 1.22 0.96 0.70, 1.32 0.94 0.70, 1.27 0.96
 Benefits/side effects of the antipsychotic explained 7421/10,461 0.93 0.79, 1.10 1.15 0.96, 1.37 0.97 0.70, 1.35 1.20 0.86, 1.68 0.31
Psychological treatments
 CBT ever offered 3578/10,495 0.73 0.61, 0.86 0.74 0.63, 0.88 0.69 0.49, 0.97 1.10 0.82, 1.48 < 0.001
 Family therapy ever offered 1554/10,493 1.53 1.26, 1.86 0.76 0.60, 0.95 1.39 0.93, 2.06 1.01 0.70, 1.47 < 0.001
Care planc
 Service user has a current care plan 5263/5520 0.50 0.33, 0.76 1.29 0.74, 2.26 0.53 0.26, 1.10 2.38 0.56, 10.12 0.002
  1. Reference group for all analyses is the ‘White’ ethnicity group
  2. All models adjust for age, sex, managing team, duration of illness, diagnosis, remission and NAS survey year
  3. aExcludes people prescribed combination of drugs, no drugs or clozapine
  4. bClozapine restricted to people not in remission (partial remission with substantial disability or not in remission at all)
  5. cSecond wave only
  6. LRT likelihood ratio test, OR odds ratio, CI confidence interval, SGA second generation antipsychotic, FGA first generation antipsychotic, BNF British National Formulary, NAS National Audit of Schizophrenia